PSOPA

Phase-sensitive optical parametric amplifiers

 Coordinatore CHALMERS TEKNISKA HOEGSKOLA AB 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Sweden [SE]
 Totale costo 2˙499˙264 €
 EC contributo 2˙499˙264 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2011-ADG_20110209
 Funding Scheme ERC-AG
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-03-01   -   2017-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    TALLINNA TEHNIKAULIKOOL

 Organization address address: Ehitajate tee 5
city: TALLINN
postcode: 19086

contact info
Titolo: Mrs.
Nome: Liina
Cognome: Kotkas
Email: send email
Telefono: +37250 22588

EE (TALLINN) beneficiary 167˙710.80
2    CHALMERS TEKNISKA HOEGSKOLA AB

 Organization address address: -
city: GOETEBORG
postcode: 41296

contact info
Titolo: Ms.
Nome: Ingrid
Cognome: Collin
Email: send email
Telefono: +46 31 7721601

SE (GOETEBORG) hostInstitution 2˙331˙553.20
3    CHALMERS TEKNISKA HOEGSKOLA AB

 Organization address address: -
city: GOETEBORG
postcode: 41296

contact info
Titolo: Prof.
Nome: Peter Avo
Cognome: Andrekson
Email: send email
Telefono: +46 31 7721606

SE (GOETEBORG) hostInstitution 2˙331˙553.20

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

communication    telecom    psa    broad    noise    materials    signal    amplifiers    compact    ultrafast    transmission    gain    psas    bandwidth    optical    capacity    loss    nonlinear   

 Obiettivo del progetto (Objective)

'Optical amplifiers are essential in optical communication systems as they compensate loss induced by the transmission fiber ensuring signal integrity of the information being transmitted, as well as in other applications such as spectroscopy.

This research proposal deals with phase-sensitive optical parametric amplifiers (PSA) that have unique and superior properties compared with all other optical amplifiers, most notably the potential of noiseless amplification, very broad optical bandwidth, and being an enabler of a range of ultrafast all-optical functionalities. In communication, there is an urgent need to develop new technologies that can break the ‘nonlinear Shannon capacity limit’, which is considered a serious barrier for continued capacity increase needed to meet the exponentially growing demand for bandwidth. The use of PSAs is expected to be an essential part of this development.

The objective is to unleash the unexplored potential of PSAs by generating knowledge and implementing experimental demonstrations that go substantially beyond current state-of-the-art. This involves a mix of engineering and scientific challenges with telecom and non-telecom applications in mind. We will leverage advances in other areas e.g. low loss photonic crystal fibers and highly nonlinear materials to realize compact PSAs with unprecedented performance. Specifically, we will demonstrate:

• Significant merits (reach, spectral efficiency, capacity) of PSAs in optical transmission systems • High coherence, low noise lasers by utilizing ultralow noise amplifier as gain element • Very broad gain bandwidth, low noise PSAs using specially tailored nonlinear gain medium • Compact (hybrid integration compatible) PSA using new nonlinear materials • Novel ultrafast all-optical operations/signal processing using PSAs • Capability of PSAs for detection of very weak optical signals for e.g. and quantum optics'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

TUDOR (2010)

Towards Understanding the Structure and Dynamics of Receptor Proteins

Read More  

INTERRUPTB (2013)

"Estimating the effective reproductive rate of M. tuberculosis from changes in molecular clustering rates, to measure the impact of public health interventions on TB transmission"

Read More  

CYTOTOXICTISALANS (2012)

Salan Ti(IV) Complexes as Novel Anti-Cancer Chemotherapeutics

Read More